Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMAX Clinical Research is Australia’s largest and most experienced dedicated early-phase clinical trial unit. It has completed over 800 clinical trials, including over 200 first-in-human studies. CMAX runs more than 60 clinical trials annually, serving biotechnology and pharmaceutical companies globally. It is recognized for high-quality, ethical, and scientifically robust Phase 1 research, including novel psychedelic and biologic investigational medicines. Notable recent Phase 1 studies involve innovative assets from companies such as Holoclara, Cyclarity Therapeutics, and Bright Minds Biosciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMAX Group.